Target intelligence / Profile preview

Sorting nexin-31 (SNX31)

Target
SNX31
Molecular classification
Other (Endocytic trafficking/scaffolding protein), PX domain-containing protein, FERM domain-containing protein
01

Overview

Sorting nexin-31 (SNX31) is a member of the sorting nexin (SNX) family, which comprises cytoplasmic proteins primarily involved in endosomal protein trafficking and homeostasis[1][2][5]. SNX31 contains both a PX (phox-homology) domain, which binds phosphoinositides and targets the protein to membrane compartments, and a FERM (4.1/ezrin/radixin/moesin-like) domain, which enables binding to other protein partners such as β1-integrin[3]. SNX31 is highly and specifically expressed in terminally differentiated bladder urothelial umbrella cells and is co-expressed with uroplakin proteins, playing a role in the trafficking and degradation of uroplakin-rich vesicles through the multivesicular body (MVB) pathway in these cells[1]. Additionally, its interaction with β1-integrin implicates SNX31 in integrin-mediated signaling and vascular integrity, and a mutation in SNX31 has been associated with autosomal dominant familial exudative vitreoretinopathy (FEVR), a disorder of retinal vascularization[3]. SNX31 does not currently have known pharmacological modulators or established biomarker applications. Although its primary roles are in cellular trafficking and membrane homeostasis, the SNX family’s dysfunction is broadly linked to various human diseases, including neurodegenerative and vascular disorders[1][3][4].

Other names
Sorting nexin 31SNX31MGC39715
02

Biological functions

Protein trafficking (endocytic recycling)Regulation of protein degradation (lysosomal and exosomal)Membrane association via phosphoinositide bindingModulation of integrin surface levels and stability
03

Disease associations

Vascular disease (Familial exudative vitreoretinopathy, FEVR)[3]Potential implication in neurodegenerative disease (link via sorting nexin family)[1]Protein trafficking disorders

Beyond the preview

Go deeper on Sorting nexin-31 (SNX31).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sorting nexin-31 (SNX31).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call